MIG Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-56,509
Closed -$18.3M 45
2025
Q3
$18.3M Sell
56,509
-3,125
-5% -$972K 2.65% 15
2025
Q2
$23.2M Sell
59,634
-9,780
-14% -$3.93M 2.39% 19
2025
Q1
$30.2M Sell
69,414
-30,184
-30% -$12.1M 3.75% 13
2024
Q4
$36.7M Buy
99,598
+5,140
+5% +$2.15M 3.78% 13
2024
Q3
$49.1M Sell
94,458
-11,065
-10% -$5.91M 5.96% 8
2024
Q2
$57.2M Sell
105,523
-7,411
-7% -$3.92M 7.62% 4
2024
Q1
$58.6M Hold
112,934
8.14% 5
2023
Q4
$53.3M Hold
112,934
7.44% 5
2023
Q3
$49.2M Buy
+112,934
New +$51.2M 9.1% 4
2018
Q3
Sell
-1,472
Closed -$350K 42
2018
Q2
$350K Buy
+1,472
New +$341K 0.05% 24
2014
Q4
Sell
-1,779
Closed -$213K 29
2014
Q3
$213K Buy
+1,779
New +$204K 0.08% 24

Other funds holding ELV

MIG Capital's ELV Position: Q4 2025 in Review

MIG Capital sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 56,509 shares — an estimated $18.3M sold.

MIG Capital first reported a position in ELV in Q3 2014 and held it in 11 quarters. The position peaked at $58.6M in Q1 2024. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • MIG Capital reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • MIG Capital sold 56,509 Elevance Health shares in Q4 2025, an estimated $18.3M.
  • MIG Capital first reported a position in Elevance Health in Q3 2014 and held it in 11 quarters.
  • MIG Capital's Elevance Health position peaked at $58.6M in Q1 2024.
  • 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on MIG Capital's 13F filing for Q4 2025, filed 17 Feb 2026.